Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 No-Brainer Stocks to Buy in September

TheMotleyFool 
0 0 31.08.24
3 No-Brainer Stocks to Buy in SeptemberPhoto, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
 

Don't want to think too hard about your investing decisions? Then go with the stocks of highly profitable companies with strong growth prospects.

Three Motley Fool contributors identified several stocks that fit this description. Here's why they think Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX) are no-brainer healthcare stocks to buy in September.

David Jagielski (Eli Lilly): Eli Lilly continually gives investors reason to become even more bullish on its already plentiful growth opportunities. Right now, it's all about the growing upside and potential for tirzepatide -- the active ingredient in its type 2 diabetes and weight loss drugs, Mounjaro and Zepbound.

Continue reading


Source Fool.com

Vertex Pharmaceuticals Inc. Stock

€469.30
1.380%
Vertex Pharmaceuticals Inc. gained 1.380% today.
The stock is one of the favorites of our community with 42 Buy predictions and 1 Sell predictions.
With a target price of 475 € there is a slightly positive potential of 1.21% for Vertex Pharmaceuticals Inc. compared to the current price of 469.3 €.
Show more
Like: 0
VRTX
Share

Comments

Not a member yet? Sign up for free!